Member Info for SGD27

My existing holding was N.

I applied for 1.75 x N.

I was allocated 0.349 x N.

So roughly 20% of what I'd applied for.

Still waiting on my HL account, but I assume they'll do the same.

@Couerdelion I've just checked my II account and they're only letting me have 34.9% of my existing holding. I'd applied for a lot more, so I was really hoping I was wrong and you were right! :-(

I hardly dare say it, but it does feel as if a corner may have been turned here. I wonder if Simon Thompson might now reconsider his stance?

Https://www.thisismoney.co.uk/money/markets/article-15913681/SMALL-CAP-MOVERS-Ascent-Resources-braces-day-reckoning.html

"For Frontier IP, down 25 per cent, the story is more nuanced and may very well be a case of short-term pain for significant long-term gain.

Shore Capital reckons Frontier could finally be reaching the 'harvest stage' after years of patient capital deployment, with substantial value locked in six core holdings.

The broker sees a significant gap between the 17p share price and conservative valuations of underlying assets, with each core holding potentially worth at least 20p per Frontier IP share on realisation.

Shore's base case implies 170p of value, with bull cases reaching 230p to 290p, supported by the Exscientia precedent, which turned a £2,000 stake into roughly £14 million in cash.

Current holdings include Pulsiv, valued at £60 million and flagged as an IPO candidate; Alusid, exploring an AIM flotation; and 2D Photonics, which secured €211 million in Italian state aid that Shore says implies 22p of value per Frontier IP share.

A planned £4 million equity raise and up to £2 million of debt is designed to extend the runway without forcing premature exits."

If I've understood correctly, the oversubscription means that the allocation of new shares will be capped at about 35% of one's existing holding (72% x 48.476%). Anyone concur?

BW article yesterday, discussing SC2 (the Cambridge hub):

https://www.businessweekly.co.uk/posts/fresh-frontiers-as-ip-power-player-takes-academic-excellence-to-the-world

Also Fieldwork news articles today:

https://ukinvestormagazine.co.uk/seed-innovations-backs-robotics-firm-tackling-fruit-picking-crisis/

Https://www.proactiveinvestors.co.uk/companies/news/1094036/frontier-ip-discount-looks-stretched-as-core-portfolio-approaches-harvest-1094036.html

Molendotech progressing at the Great Lakes:

https://www.leelanaunews.com/article/8013%2Cbeach-monitoring-begins

"Results from the pilot will be compared with traditional testing methods and shared with researchers at Michigan State University and the University of Michigan, contributing to ongoing statewide evaluations of this technology."

So some free independent testing for BactiQuick - let's hope it's successful.

Episode 214:

https://www.youtube.com/watch?v=wz-z7Z44Vx4

"View from Vox

With EBITDA likely to run into the hundreds of millions of dollars when Tulu Kapi moves into production, KEFI’s accounts are unlikely to look like this for much longer. The company closed out the year with £8.7 million in the bank, and has done subsequent fundraising to see it through the construction phase. With gold continuing strong well above US$4,000, the margins on offer at Tulu Kapi are substantial."

https://www.vo%78markets.com/articles/kefi-posts-full-year-accounts-as-tulu-kapi-construction-proceeds-apace-9978790

Https://www.vo%78markets.com/articles/kefi-gold-copper-could-a-district-scale-play-now-emerge-around-tulu-kapi-ea3076d

Spot = 84.18 (was 86.35 in April)

Long-term = 94.00 (was 91.50 in April)

https://www.cameco.com/invest/markets/uranium-price

Spot lagging a lot now. Looking at their chart, you'd think it might be due to whiplash back up soon, hopefully. Only $76ish to buy here, so I decided it's a good time to add!

Good news for Genmab, which I believe have a substantial royalty on amivantamab. Might this mean they end up with more cash available to deploy in our direction?

https://www.theguardian.com/science/2026/may/30/cancer-jab-can-eradicate-entire-tumours-in-patients-trial-shows

08:55 in video

https://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-wednesday-27th-may-2026/

Picked up by the Guardian:

https://www.theguardian.com/business/2026/may/27/recycled-tile-startup-pilot-deal-dekiln-johnson-tiles

Https://www.vo%78markets.com/research#/rnid/30_a7f2316d-50f0-498f-88b8-e30e18d03215

Would a move to the LSE main market help? There are FTSE250 companies with mcap less than £400m.

It's here:

https://maps.app.goo.gl/Gh6Ec7B7t7Syy4mm7

Anyone in Manchester a week today?

https://www.eventbrite.com/e/dekiln-open-day-tickets-1989210681697

April numbers:

Spot = 86.35 (was 84.25 in March)

Long-term = 91.50 (unchanged from March)

Sorry, 2nd link was meant to be this:

https://fieldworkrobotics.com/fieldwork-signs-collaboration-agreement-with-dynium/